Safe Medical inaugurates its Integrated Innovation and Production Centre (CIPI) on the Fleurieux-sur-l’Arbresle (69) industrial site
|
Safe Medical inaugurates its Integrated Innovation and Production Centre (CIPI) on the Fleurieux-sur-l’Arbresle (69) industrial site
| ||
Éragny-sur-Oise, Fleurieux-sur-l’Arbresle, October 13, 2021 at 5:45 pm CET – Safe Orthopaedics (FR0013467123 – ALSAF), a company specializing in the design, manufacture and marketing of ready-to-use technologies for back surgery, particularly safe for emergency-treated vertebral fractures, has announced the inauguration of its Center for Innovation and Integrated Production (CIPI), on the Fleurieux-sur-l’Arbresle (69) industrial site. Operational since September, the CIPI includes two clean rooms dedicated to the packaging of medical devices and a titanium 3D printing module for the design of implants and surgical tools. It complements the production lines and the R&D unit set up in 2020 and entirely dedicated to orthopedic surgery.
Safe Orthopaedics acquired Safe Medical (Ex-LCI Medical) in 2020. Since then, the company has invested €2.5 million in the Fleurieux-sur-l’Arbresle site, making it a leading industrial complex in Europe for the innovation and production of medical devices for orthopedic surgery. One million euros were devoted to the renovation and extension of the buildings, and nearly 1.5 million to the technological re-equipment of the site (1.5 million euros). The Safe Group received support from Bpifrance for this project, via a €0.8 million innovation loan.
The activity of the Safe Medical site is driven by the recovery of the subcontracting activity, with volumes now higher than their pre-crisis level, and by the internationalisation of the production of Safe Orthopaedics’ proprietary innovations.
Pierre Dumouchel, Chairman and CEO of Safe Orthopaedics, said: “We are delighted that our Integrated Innovation and Production Centre (CIPI) is now up and running, in line with the timetable we set ourselves a year ago when we launched the work. The integration of the entire value chain, from R&D to manufacturing, on the same site allows us to streamline our processes, with an economic and environmental impact, while also giving us the means to radically accelerate the innovation cycle. We will continue to invest in the Fleurieux-sur-l’Arbresle site to maintain the excellence of this industrial site and ensure our leadership in spine surgery.”
About Safe Group
Safe Group is a French medical technology group that brings together Safe Orthopaedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgery. The group employs approximately 150 people.
Safe Orthopaedics develops and manufactures kits combining sterile implants and single-use instruments, available at any time to the surgeon. These technologies are part of a minimally invasive approach aimed at reducing the risk of contamination and infection, for the benefit of the patient and with a positive impact on hospitalization times and costs. Protected by 18 patent families, SteriSpineTM kits are CE marked and FDA approved. Safe Orthopaedics is headquartered in the Paris region (Eragny-sur-Oise (95610)) and has subsidiaries in the United Kingdom, Germany, the United States and the Lyon region (Fleurieux-sur-l’Arbresle).
For more information: www.safeorthopaedics.com
Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation centre and two production sites in France (Fleurieux-sur-l’Arbresle, 69210) and Tunisia, offering a wide range of industrial services: design, industrialisation, machining, finishing and sterile packaging. Supported by the French recovery plan in 2020, the company invests in additive printing and will be operational in 2022 on this new technology.
For more information: www.safemedical.fr
Contacts
Safe Orthopaedics
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50 00
investors@safeorthopaedics.com
Press Relations
Ulysse Communication
Pierre-Louis Germain / +33 (0)6 64 79 97 51 / plgermain@ulysse-communication.com
Bruno Arabian / +33 (0)6 87 88 47 26 / barabian@ulysse-communication.com
Attachment
